Vascular Smooth Muscle Sirtuin-1 Protects Against Diet-Induced Aortic Stiffness

Hypertension. 2016 Sep;68(3):775-84. doi: 10.1161/HYPERTENSIONAHA.116.07622. Epub 2016 Jul 18.

Abstract

Arterial stiffness, a major cardiovascular risk factor, develops within 2 months in mice fed a high-fat, high-sucrose (HFHS) diet, serving as a model of human metabolic syndrome, and it is associated with activation of proinflammatory and oxidant pathways in vascular smooth muscle (VSM) cells. Sirtuin-1 (SirT1) is an NAD(+)-dependent deacetylase regulated by the cellular metabolic status. Our goal was to study the effects of VSM SirT1 on arterial stiffness in the context of diet-induced metabolic syndrome. Overnight fasting acutely decreased arterial stiffness, measured in vivo by pulse wave velocity, in mice fed HFHS for 2 or 8 months, but not in mice lacking SirT1 in VSM (SMKO). Similarly, VSM-specific genetic SirT1 overexpression (SMTG) prevented pulse wave velocity increases induced by HFHS feeding, during 8 months. Administration of resveratrol or S17834, 2 polyphenolic compounds known to activate SirT1, prevented HFHS-induced arterial stiffness and were mimicked by global SirT1 overexpression (SirT1 bacterial artificial chromosome overexpressor), without evident metabolic improvements. In addition, HFHS-induced pulse wave velocity increases were reversed by 1-week treatment with a specific, small molecule SirT1 activator (SRT1720). These beneficial effects of pharmacological or genetic SirT1 activation, against HFHS-induced arterial stiffness, were associated with a decrease in nuclear factor kappa light chain enhancer of activated B cells (NFκB) activation and vascular cell adhesion molecule (VCAM-1) and p47phox protein expressions, in aorta and VSM cells. In conclusion, VSM SirT1 activation decreases arterial stiffness in the setting of obesity by stimulating anti-inflammatory and antioxidant pathways in the aorta. SirT1 activators may represent a novel therapeutic approach to prevent arterial stiffness and associated cardiovascular complications in overweight/obese individuals with metabolic syndrome.

Keywords: aorta; arterial stiffness; cardiovascular disease metabolic syndrome obesity sirtuin-1 vascular smooth muscle.

Publication types

  • Comparative Study

MeSH terms

  • Animals
  • Blotting, Western
  • Cardiovascular Diseases / prevention & control
  • Diet, High-Fat / adverse effects*
  • Disease Models, Animal
  • Glucose Tolerance Test
  • Male
  • Metabolic Syndrome / prevention & control
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Mice, Transgenic
  • Muscle, Smooth, Vascular / cytology
  • Muscle, Smooth, Vascular / drug effects
  • Obesity / physiopathology*
  • Pulse Wave Analysis
  • Random Allocation
  • Real-Time Polymerase Chain Reaction
  • Resveratrol
  • Sirtuin 1 / pharmacology*
  • Stilbenes / pharmacology
  • Vascular Cell Adhesion Molecule-1 / metabolism*
  • Vascular Stiffness / drug effects*

Substances

  • Stilbenes
  • Vascular Cell Adhesion Molecule-1
  • Sirtuin 1
  • Resveratrol